Quantcast

Latest Pyrimidines Stories

2014-07-16 12:28:12

If isavuconazole is approved for invasive candidiasis, QIDP status provides a five-year extension of market exclusivity. NORTHBROOK, Ill., July 16, 2014 /PRNewswire/ -- Astellas today announced that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive candidiasis, a life-threatening, invasive fungal infection. http://photos.prnewswire.com/prnvar/20140416/84970 A product that is granted...

2014-07-15 12:29:21

The Upcoming Entry of New Generation TKIs will Challenge the Established Position of CML Treatments in Brazil and Mexico, According to Findings from Decision Resources Group BURLINGTON, Mass., July 15, 2014 /PRNewswire/ -- Decision Resources Group finds that, despite the fact that the treatment armamentarium for chronic myeloid leukemia (CML) in Brazil and Mexico includes all three tyrosine kinase inhibitors (TKIs)--Novartis' Glivec (imatinib), Bristol-Myers Squibb's Sprycel (dasatinib) and...

2014-06-02 12:28:29

High Cost and High Expectations for Clinical Benefits are Major Market Access Hurdles Facing New CML Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., June 2, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed hematologists in China estimate that Novartis's Glivec (imatinib) will lose nearly half of its patient share for treatment of chronic myeloid leukemia (CML) in the next three years, due to the market entry of generic imatinib. Nevertheless,...

2014-05-27 12:32:14

Robust Value Dossiers and Smart Uptake Strategies are Vital to Secure Optimal Market Access in Europe, According to Findings from Decision Resources Group BURLINGTON, Mass., May 27, 2014 /PRNewswire/ -- Decision Resources Group finds that Novartis's Glivec is the clear agent of choice for first-line treatment of chronic myelogenous leukemia (CML) patients in the chronic phase, according to surveyed hematological oncologists from France, Germany, Italy, Spain and the United Kingdom (EU5). Use...

2014-05-12 23:08:41

Pulmonary arterial hypertension – a deadly, incurable lung condition – is one of only sixteen disease states FDA will focus on during the first three years of the Patient Focused Drug Development Initiative. The meeting represents a historic opportunity for patient input. Silver Spring, MD (PRWEB) May 12, 2014 On Tuesday, May 13, the Food and Drug Administration and the Pulmonary Hypertension Association will host a unique conversation between FDA drug reviewers and pulmonary arterial...

2014-04-29 23:11:40

CML-IQ delivers timely, accurate information to help people make informed decisions. Montreal, QC (PRWEB) April 29, 2014 Every day in North America, about 16 people are diagnosed with a form of blood cancer called chronic myelogenous leukemia (CML). This disease is characterized by an abnormal proliferation of white blood cells, which results in bruising, a swollen spleen and bleeding complications. Until recently, life expectancy was only a few years for people diagnosed with CML. That...

2014-04-10 12:22:45

DUBLIN, Apr. 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2798mr/global_and ) has announced the addition of the "Global and Chinese Azoxystrobin Industry Report 2014" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The Global and Chinese Azoxystrobin Industry Report 2014 is a professional and in-depth study on the current state of the global azoxystrobin industry with a focus on the Chinese situation. The...

2014-04-01 23:02:31

In-demand research report “Production and Market of Azoxystrobin in China” elaborated by Guangzhou CCM Information Science & Technology Co (CCM) is available at MarketPublishers.com. According to the study, China's azoxystrobin market is forecast to see robust growth through 2018. London, UK (PRWEB) April 01, 2014 After the expiry of azoxystrobin technical's patent in February of 2010, the Chinese azoxystrobin production has grown at a robust pace. At present, China has an...

2014-03-28 12:22:04

DUBLIN, Mar. 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/44vxfn/investigation ) has announced the addition of the "Investigation Report on China Imatinib Market, 2009-2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Incidence of chronic myelogenous leukemia (CML) varies in the world. The global incidence is about 10/1,000,000 while in China it is 4/1,000,000. CML takes up about 20% of leukaemia in China...

2014-03-10 08:22:19

-- Bayer's Adempas (riociguat tablets) approved for the treatment of pulmonary arterial hypertension (PAH)(1), which affects up to 2000 Canadians(2) -- Adempas provides novel and specific approach to treat different types of pulmonary hypertension (PH), a serious condition of the heart and lungs -- Only drug in Canada indicated to treat two rare types of PH - PAH and chronic thromboembolic pulmonary hypertension (CTEPH)(1,3) TORONTO, March...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related